The Malaysian Research Accelerator for Technology and Innovation (MRANTI) has made a strategic move by introducing the Malaysia Technology Commercialisation Platform (MATCH), aimed at fortifying the connections within the technology innovation ecosystem.
MATCH serves as a monetisation platform for technology innovation, fostering connections and offering mutually beneficial solutions to local technology providers and seekers, thus expediting technology commercialisation in Malaysia.
“Much like an e-commerce site, MATCH is a hub for every individual and organization in the innovation ecosystem. By establishing connections among all interested parties, we aim to create a more cohesive, transparent, and consistent perspective on opportunities and gaps in the local technology commercialisation landscape,” said Dzuleira Abu Bakar, CEO of MRANTI.
The initial phase is set to feature 50 innovation seekers and providers, with a targeted success rate of 10% for successful matches.
Through MATCH, researchers, investors, experts, and individuals in various stages of technology development seeking industry partnerships, funding, sandbox sites, technical support, and collaboration can navigate the directory to find suitable prospects.
The platform functions as a dynamic marketplace, offering a list of projects categorized based on Technology Readiness Level and specific use cases.
MATCH was inaugurated by Prime Minister Dato’ Seri Anwar Ibrahim, and witnessed by MOSTI Minister, Chang Lih Kang, during the Malaysia Commercialisation Year Summit 2023 (MCY Summit 2023).
Moreover, government bodies, ministries, corporates, and businesses in search of new technology innovations or solution partners can seamlessly connect via the platform.
The platform also synergises with other initiatives and databases, including the Malaysia Open Science Platform by Akademi Sains Malaysia, extending scientific and academic work from laboratories to the market, where innovative technology aligns with profitable use cases. It’s also designed to support forums on licensing, investments, and more.
While Gross Domestic Product (GDP) has traditionally measured a nation’s success, the United Nations has emphasized that “innovation and creativity have become the true wealth of nations in the 21st century.”
“In advancing the country’s economic and social development, we must foster more value through innovation. Intellectual Property and innovation translate into tangible and intangible wealth,” said Dzuleira.
Registration on MATCH is free for technology seekers and providers. For details, visit MRANTI’s IP services or email: firstname.lastname@example.org.
MRANTI’s Collaborations with AstraZeneca and EAHSN Bring New Opportunities for Healthcare Innovators
In addition, MRANTI entered into two separate Memorandums of Understanding (MoUs) during the MCY Summit 2023, partnering with pharmaceutical giant AstraZeneca and the Eastern Academic Health Science Network (EAHSN) – a UK government-linked company funded by the National Healthcare Service (NHS) and the Office for Life Sciences.
These initiatives unite academia, citizens, healthcare services, and industry to expedite the value realization of healthtech innovations. AstraZeneca will consider promising local innovators for inclusion in its exclusive A.Catalyst network. This global network comprises over 20 AstraZeneca health innovation hubs, both physical locations and virtual partnerships.
As the exclusive partner for the A.Catalyst program in Malaysia, MRANTI will channel Malaysian innovators into a global healthcare player network, granting access to AstraZeneca’s worldwide networks for clinical or real-world evidence evaluation, as well as EAHSN’s reach in the UK. This includes research and development activities, market access, strategic partnerships, joint ventures, and other business growth opportunities.
Simultaneously, MRANTI will leverage its experience in running Sandbox and capability programs, providing innovators, researchers, startups, and high-tech entrepreneurs with a secure live environment to develop and test products, services, business models, and delivery mechanisms.